EXTON, Pa.--(BUSINESS WIRE)--Feb. 28, 2006--Antares Pharma, Inc. (Amex:AIS) announced today that it has signed a definitive agreement to raise $10,962,500 through a private placement of 8,770,000 shares of common stock to a group of accredited investors at $1.25 per share. Additionally, investors will receive warrants to purchase 6,577,500 shares of common stock at an exercise price of $1.50 per share. The completion of the private placement is subject to approval by the American Stock Exchange and other customary closing conditions.
